Vea Impex
Send Inquiry
Vea Impex  Banner

Xeloda Tablets

Xeloda Tablets
Xeloda Tablets
Send Inquiry
Product Code : 00
Price And Quantity
  • Minimum Order Quantity
  • 1 Box
  • Price
  • 1195 INR/Piece
Product Specifications
  • Storage Instructions
  • Room temperature
  • Shelf Life
  • 1 Years
Product Description
 Brand Name  Xeloda Tablet
 Generic Name  Capecitabine
 Manufactured By  Roche Pharma
 Form  Tablet
 Strength  500 mg
 Quantity  120 tablets
 Usage  For oral use

Xeloda (Capecitabine) tablet is an anti cancer medicine that is used to treat breast, colon or rectal cancer. It works by stopping the spread or multiplication of virus in the body. Often, this medicine is used in combinations with other cancer medicatons to increase infectiveness in treatment.

Xeloda tablet should be taken with food or within 30 minutes after eating a meal. It is advisible to take this medicine with glass of water.

Xeloda (Capecitabine) tablet should be under proper medical guidance and advice only. Before consuming, consult your doctor the exact dose and the time when it should be taken. Also, keep in mind that if you see any sign of side effects after consuming, immediately call the physician for advise. Not all patients are suitable to take this kind of medicine.

Side Effects:

  • Abdominal or stomach pain
  • diarrhea
  • diarrhea
  • blistering
  • tingling
  • nausea
  • unusual tiredness or weakness
  • ulcers in your mouth or on your lips
  • vomiting
  • back pain
  • chest pain
  • constipation
  • drowsiness
  • chills
Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 10000 Box Per Week
  • Delivery Time
  • 15-20 Days
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Main Domestic Market
  • All India

VEA IMPEX
X


"We mainly deliver our products to the foreign countries."
VEA IMPEX All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.